2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Neoplasms
4
Breast Neoplasms
4
Oropharyngeal Neoplasms
2
Motor Activity
2
Brain Neoplasms
2
Uveal Melanoma
1
Suicidal Ideation
1
Stomach Ulcer
1
Stomach Neoplasms
1
Skin Cancer Face
1
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polycystic Ovary Syndrome
1
Parotid Neoplasms
1
Mouth Neoplasms
1
Meningeal Carcinomatosis
1
Lung Neoplasms
1
Li-Fraumeni Syndrome
1
Hyperandrogenism
1
Hematologic Diseases
1
Head and Neck Neoplasms
1
Hamartoma Syndrome, Multiple
1
Glioblastoma
1
Gastrointestinal Hemorrhage
1
Gastrointestinal Diseases
1
Gastritis
1
Disability Physical
1
Depression
1
Colorectal Neoplasms, Hereditary Nonpolyposis
1
Carcinoma in Situ
1
Interventions
Sirolimus
3
Everolimus
2
dactolisib
1
Physical Examination
1
Mastectomy, Subcutaneous
1
Mastectomy
1
Fluorodeoxyglucose F18
1
Colonoscopy
1
8-(6-methoxypyridin-3-yl)-3-methyl-1-(4-piperazin-1-yl-3-trifluoromethylphenyl)-1,3-dihydroimidazo(4,5-c)quinolin-2-one
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Hamartoma Syndrome, Multiple
×
Physical Examination
×
Clear all
NCT06712095
2024-12-05
PILLCAM
Royal Marsden NHS Foundation Trust
Phase NA
Recruiting
25 enrolled